C. Gotera Rivera (Madrid, Spain), A. Bossios (Stockholm, Sweden)
Changes in critical inhaler technique errors in inhaled COPD treatment – a one-year follow-up study in Sweden
J. Sulku (Uppsala, Sweden), C. Janson (Uppsala, Sweden), H. Melhus (Uppsala, Sweden), B. Ställberg (Uppsala, Sweden), K. Bröms (Uppsala, Sweden), M. Högman (Uppsala, Sweden), K. Lisspers (Uppsala, Sweden), A. Malinovschi (Uppsala, Sweden), E. Nielsen (Uppsala, Sweden)
|   |
Exacerbation outcome definitions in clinical trials of COPD interventions: a systematic review
T. Bradbury (Newtown, Australia), S. Ananth (Watford, United Kingdom), S. Hussaini (Liverpool, Australia), A. Mathioudakis (Manchester, United Kingdom), R. Nguyen (Liverpool, Australia), C. Jenkins (Newtown, Australia)
| |
Clinically important deterioration in patients with COPD: a post-hoc analysis of ETHOS
D. Singh (Manchester, United Kingdom), F. Martinez (New York, NY, United States), J. Hurst (London, United Kingdom), M. Han (Ann Arbor, MI, United States), P. Darken (Gaithersburg, MD, United States), M. Patel (Cambridge, United Kingdom)
| |
Estimation and visual representation of hospital costs after an acute exacerbation of COPD. COHERENT-COPD study.
M. Tejedor Oritz (Madrid, Spain), J. Sánchez-Covisa Hernández (Madrid, Spain), C. Goñi Echeverría (Madrid, Spain), H. Bueno Zamora (Madrid, Spain), J. Bernal Sobrino (Madrid, Spain), M. Juarez Campo (Madrid, Spain), M. Piñeiro Roncal (Madrid, Spain), G. Siesto López (Madrid, Spain), C. Alvarez Martínez (Madrid, Spain)
| |
Effect of a technology-enabled respiratory in-reach service on reduction in the inappropriate use of oral corticosteroids (OCS) for suspected Airways Disease exacerbations (ADE) in an acute general hospital
A. Al Helou (Birmingham (West Midlands), United Kingdom), G. Chellappah (Birmingham (West Midlands), United Kingdom), K. Jones (Birmingham (West Midlands), United Kingdom), P. Ellis (Birmingham (West Midlands), United Kingdom), A. Mansur (Birmingham (West Midlands), United Kingdom), R. Mukherjee (Birmingham (West Midlands), United Kingdom), P. Ellis (Solihull, United Kingdom)
| |
Clinical efficacy of anemia of chronic disease treatment in patients with COPD.
A. Kovchun (Sumy, Ukraine), V. Kachkovska (Sumy, Ukraine), A. Bondarkova (Sumy, Ukraine), L. Prystupa (Sumy, Ukraine)
| |
Time trends (2012-2020) and sex differences for influenza vaccination uptake among individuals with chronic obstructive pulmonary disease in Spain.
M. Fuentes Alonso (Madrid, Spain), I. DOMINGUEZ ZABALETA (Madrid, Spain), C. Correa Gutiérrez (Madrid, Spain), C. Sanchez Gutierrez (Madrid, Spain), G. Manzanares Cavi (Madrid, Spain), M. Mor Martinez (Madrid, Spain), L. Puente Maestu (Madrid, Spain), J. De Miguel Diez (Madrid, Spain)
| |
Reduced exacerbations following switch from multiple-inhaler to once-daily single-inhaler triple therapy in COPD patients in a real-world primary care setting in England
K. Rothnie (Brentford, United Kingdom), R. Wood (Bollington, United Kingdom), A. Czira (Brentford, United Kingdom), V. Banks (Bollington, United Kingdom), L. Camidge (Bollington, United Kingdom), O. Massey (Bollington, United Kingdom), M. Seif (Bollington, United Kingdom), C. Compton (Brentford, United Kingdom), R. Sharma (Brentford, United Kingdom), A. Ismaila (Collegeville, United States)
| |
Identifying risk of first COPD exacerbation in COPD patients in GOLD group A/B in the UK
K. Rothnie (London, United Kingdom), S. Gelwicks (Collegeville, United States), B. Numbere (London, United Kingdom), Y. Lu (North Carolina, United States), R. Sharma (London, United Kingdom), C. Compton (London, United Kingdom), A. Ismaila (Collegeville, United States)
| |
COPD as a risk factor for Coronary Artery Disease (CAD): Overview of 10-year atherosclerotic cardiovascular disease (ASCVD) risk assessment
D. Buklioska Ilievska (Skopje, North Macedonia), J. Minov (Skopje, North Macedonia), N. Kochovska Kamchevska (Skopje, North Macedonia), I. Mickovski (Skopje, North Macedonia), T. Hasan (Skopje, North Macedonia), M. Baloski (Skopje, North Macedonia), R. Neshovska (Skopje, North Macedonia), N. Nedeska Minova (Skopje, North Macedonia), B. Prgova-Veljanova (Skopje, North Macedonia), D. Doneva (Skopje, North Macedonia), V. Trajkovska (Skopje, North Macedonia), M. Simeonova (Skopje, North Macedonia), J. Bushev (Skopje, North Macedonia)
| |
Utilization of exacerbation-related drugs by COPD patients with Arg16Gly polymorphism of ADRB2 gene
K. Dmytriiev (Vinnitsya, Ukraine), Y. Mostovoy (Vinnitsya, Ukraine), N. Slepchenko (Vinnitsya, Ukraine), Y. Smereka (Vinnitsya, Ukraine), D. Dmytriiev (Vinnitsya, Ukraine), K. Dmytriieva (Vinnitsya, Ukraine)
| |
Compliance to pharmacological therapy of COPD patients with skeletal muscle dysfunction
V. Poberezhets (Vinnytsia, Ukraine), A. Demchuk (Vinnytsia, Ukraine), Y. Mostovoy (Vinnytsia, Ukraine)
| |
Risk factors and guideline adherence of empiric antibiotic use in community-acquired pneumonia
S. Pascual Guardia (Barcelona, Spain), J. Marin-Corral (Barcelona, Spain), F. Amati (Milano, Italy), S. Aliberti (Milano, Italy), M. Carugati (Milano, Italy), O. Sibila (Barcelona, Spain), F. Sanz (Valencia, Spain), A. Rodriguez (Tarragona, Spain), G. Sotgiu (Sassari, Italy), P. Marcos (A.Coruña, Spain), M. Restrepo (San Antonio, United States), .. On Behalf Of Glimp Investigators (San Antonio, United States)
| |
The role of physical rehabilitation in the treatment of COPD
K. Shvets (Ivano-Frankivsk, Ukraine), M. Ostrovskyy (Ivano-Frankivsk, Ukraine), O. Varunkiv (Ivano-Frankivsk, Ukraine), I. Savelikhina (Ivano-Frankivsk, Ukraine), M. Kulynych-Miskiv (Ivano-Frankivsk, Ukraine), G. Korzh (Ivano-Frankivsk, Ukraine), N. Korzh (Ivano-Frankivsk, Ukraine), K. Ostrovska (Ivano-Frankivsk, Ukraine)
| |
A 7-year retrospective evaluation of incidence of exacerbations in COPD patients pre and post pneumococcal vaccination. Results from RETRIEVE study.
E. Papadopoulou (Thessaloniki, Greece), M. Bertoli (Pikermi, Greece), A. Ginis (Pikermi, Greece), S. Tryfon (Thessaloniki, Greece)
| |
Association between sub-optimal medication adherence and risk of COPD diagnosis in patients with physician-diagnosed asthma: A propensity score-based analysis
M. Asamoah-Boaheng (St John's, Canada), J. Farrell (St John's, Canada), K. Bonsu (St John's, Canada), A. Oyet (St John's, Canada), W. Midodzi (St John's, Canada)
| |
Rescue medication use in patients with chronic obstructive pulmonary disease receiving umeclidinium/vilanterol versus tiotropium bromide/olodaterol in England
G. Requena (Brentford, United Kingdom), A. Czira (Brentford, United Kingdom), V. Banks (Bollington, United Kingdom), R. Wood (Bollington, United Kingdom), T. Tritton (Bollington, United Kingdom), C. Castillo (Bollington, United Kingdom), J. Yeap (Bollington, United Kingdom), R. Wild (Bollington, United Kingdom), C. Compton (Brentford, United Kingdom), M. Duarte (Brentford, United Kingdom), K. Rothnie (Brentford, United Kingdom), A. Ismaila (Collegeville, United States)
| |
Comparative effectiveness of umeclidinium/vilanterol versus indacaterol/glycopyrronium on acute exacerbations in patients with chronic obstructive pulmonary disease in England
G. Requena (Brentford, United Kingdom), A. Czira (Brentford, United Kingdom), V. Banks (Bollington, United Kingdom), R. Wood (Bollington, United Kingdom), T. Tritton (Bollington, United Kingdom), C. Castillo (Bollington, United Kingdom), J. Yeap (Bollington, United Kingdom), R. Wild (Bollington, United Kingdom), C. Chris Compton (Brentford, United Kingdom), M. Duarte (Brentford, United Kingdom), K. Rothnie (Brentford, United Kingdom), A. Ismaila (Collegeville, United States)
| |
A 7-year retrospective evaluation of lung function in COPD patients pre and post pneumococcal vaccination. Results from RETRIEVE study.
E. Papadopoulou (Thessaloniki, Greece), M. Bertoli (Pikermi, Greece), A. Ginis (Pikermi, Greece), S. Tryfon (Thessaloniki, Greece)
| |
Nebulizer use in tobacco-exposed SPIROMICS participants with or at risk of COPD
J. Fazio (Los Angeles, United States), A. Hong (Los Angeles, United States), D. Markovic (Los Angeles, United States), R. Barr (New York, United States), E. Bleecker (Tucson, United States), R. Bowler (Denver, United States), D. Couper (Chapel Hill, United States), J. Curtis (Ann Arbor, United States), B. Drummond (Chapel Hill, United States), S. Fortis (Iowa City, United States), M. Han (Ann Arbor, United States), L. Holland (Chapel Hill, United States), V. Kim (Philadelphia, United States), F. Martinez (New York, United States), J. Ohar (Winston-Salem, United States), V. Ortega (Phoenix, United States), R. Paine (Salt Lake City, United States), M. Wells (Birmingham, United States), P. Woodruff (San Francisco, United States), R. Buhr (Los Angeles, United States), C. Cooper (Los Angeles, United States), D. Tashkin (Los Angeles, United States), I. Barjaktarevic (Los Angeles, United States)
| |